The 'Dispatched' Podcast
BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.
The 'Dispatched' Podcast
Latest Episodes
The 'Dispatched' Week in Review'- 31 July (Series 5, Ep.26)
The events in the US this week surrounding a former public health leader raise some important questions in Australia about the accountability of 'independent experts'. Why we can't afford to muck up the AI opportunity as new evidence on its use...
The 'Dispatched' Podcast - Series 5, Ep.25
Misleading claims about patient groups and the industry, combined with an irrational hyperventilation about a rational response to new global realities, have made for an interesting week. The price reduction mantra and whether it can be moderat...
The 'Dispatched' Podcast - Series 5, Ep .24
A very busy week with mostly relief for patients accessing PBS-funded multiple sclerosis medicines, but what does it really mean, and what is the opportunity? Reports and their questionable citations. The most cynical use of language in our hea...
The 'Dispatched' Podcast - Series 5, Ep 23
The MS medicines controversy continues. Why wouldn’t the minister just deal with it and make it go away? It may not be that easy. Why any resolution will probably deal with symptoms rather than the cause. The realities of ministerial offices an...
The 'Dispatched' Podcast - Season 5, Episode 22
A small player with no market share and no real prospect of gaining any agreed to an almost 50 per cent price reduction to secure reimbursement. Who would have thought the market leaders would respond negatively? Discussion about the change to ...